|
Entity | Experimental design | Effects observed | Literature |
|
NSCLC | In vitro coculture study of MSCs and tumor cells | Interaction of MIF with CXCR4/SDF-1 contributes to MSCs homing | [69] |
|
Melanoma | In vivo homing of cytosine deaminase expressing MSCs in subcutaneous melanoma | MSCs abrogate tumor growth by TNF-α production | [69, 70] |
|
Breast cancer | (i) In vitro and in vivo migration of breast cancer cells to the bone marrow being facilitated by BM-MSC (ii) Coinjection of BM-MSCs and breast cancer cells | Tac1 mediated entry of breast cancer cells to the bone marrow | [38] |
|
Neuroblastoma | In vitro migration of MSCs towards neuroblastoma cell lines | Migration of MSCs depending on uPA expression | [71] |
|
Glioblastoma/brainstem glioma | (i) In vivo homing of MSCs in GL216 glioma model | (i) Presence of MSCs in the GL216 glioma model validated the homing process, change of the phenotype of tumor cells due to MSC influence; CXCR4 and CXCR6 contribute to the homing of MSCs | [72] |
(ii) In vitro migration of MSCs towards GBM cell lines | (ii) In vitro migration was mediated by HGF | [73] |
|
Mesothelioma | In vivo homing of TNF-α overexpressing MSCs in intraperitoneal mesothelioma | In vitro and in vivo induction of apoptosis in mesothelioma cells | [74] |
|
Hepatocellular carcinoma | (i) In vivo homing of MSCs in HCC | (i) MSCs primed with AMF displayed increased migratory capability to HCC and reduced MMP2 expression | [75] |
(ii) Coculture of MSCs and HCC cell lines | (ii) Increased invasiveness of HCC due to CCL5 | [76] |
|
Multiple myeloma | Decreased survival of mice after MSCs and multiple myeloma cell infusion | CCL25 production by MM cells as a chemoattractant | [77] |
|
Gastric cancer | Recruitment of BM-MSCs to gastric cancer | CXCR4/SDF-1 axis | [30] |
|
Pancreatic cancer | Transplantation of bone marrow (BM) cells into sublethally irradiated SCID mice and subcutaneous transplantation of a pancreatic cancer cell line; assessment of stromal cell contribution by BM-MSCs | High frequency of BM-derived myofibroblasts in the tumor stroma | [78] |
|